0000899243-21-012680.txt : 20210318 0000899243-21-012680.hdr.sgml : 20210318 20210318204837 ACCESSION NUMBER: 0000899243-21-012680 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210126 FILED AS OF DATE: 20210318 DATE AS OF CHANGE: 20210318 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Klickstein Lloyd CENTRAL INDEX KEY: 0001776004 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38359 FILM NUMBER: 21756202 MAIL ADDRESS: STREET 1: C/O RESTORBIO, INC. STREET 2: 500 BOYLSTON STREET, 12TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Adicet Bio, Inc. CENTRAL INDEX KEY: 0001720580 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 813305277 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 500 BOYLSTON STREET STREET 2: 12TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 617-482-2333 MAIL ADDRESS: STREET 1: 500 BOYLSTON STREET STREET 2: 12TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 FORMER COMPANY: FORMER CONFORMED NAME: resTORbio, Inc. DATE OF NAME CHANGE: 20171024 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-01-26 1 0001720580 Adicet Bio, Inc. ACET 0001776004 Klickstein Lloyd C/O ADICET BIO, INC. 500 BOYLSTON STREET, 13TH FLOOR BOSTON MA 02116 0 1 0 0 Chief Innovation Officer Common Stock 2019-12-06 4 A 0 16888 0.00 D 16888 D Common Stock 2020-10-23 4 F 0 4957 0.00 D 11931 D The Reporting Person was issued Restricted Stock Units ("RSU"). Each RSU represents a contingent right to receive one share of common stock. The RSUs shall vest in four (4) annual installments, with the first tranche vesting on December 6, 2020. The RSUs may be settled only by delivering shares of common stock, and thus, the grant is being reported in Table I as allowed per SEC guidance The amount of securities reported herein have been adjusted to reflect the 1-for-7 reverse stock split that was effected in September 2020 in connection with the merger of resTORbio, Inc. and Adicet Therapeutics, Inc., formerly known as Adicet Bio, Inc. The Reporting Person is disposing of 4,957 restricted stock units as a result of a revised tax rate for such restricted stock units /s/ Nick Harvey, Attorney-in-Fact 2021-03-18